BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1406237)

  • 21. ATSDR evaluation of potential for human exposure to benzene.
    Wilbur S; Wohlers D; Paikoff S; Keith LS; Faroon O
    Toxicol Ind Health; 2008; 24(5-6):399-442. PubMed ID: 19022881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new toxicological concept-acute reference dose].
    Liu Z; Chen B
    Wei Sheng Yan Jiu; 2003 Jan; 32(1):76-7, back cover. PubMed ID: 12731294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biological markers of exposure to toxic agents].
    Lauwerys R; Bernard A
    Rev Epidemiol Sante Publique; 1985; 33(4-5):255-61. PubMed ID: 4095327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormesis: from marginalization to mainstream: a case for hormesis as the default dose-response model in risk assessment.
    Calabrese EJ
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):125-36. PubMed ID: 15163548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The assessment of low-dose carcinogenicity.
    Armitage P
    Biometrics; 1982 Mar; 38 Suppl():119-39. PubMed ID: 7046818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomonitoring as a tool in the human health risk characterization of dermal exposure.
    Boogaard PJ
    Hum Exp Toxicol; 2008 Apr; 27(4):297-305. PubMed ID: 18684800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing.
    Gubbels-van Hal WM; Blaauboer BJ; Barentsen HM; Hoitink MA; Meerts IA; van der Hoeven JC
    Regul Toxicol Pharmacol; 2005 Aug; 42(3):284-95. PubMed ID: 15979772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of "safe doses" in carcinogenic experiments.
    Hartley HO; Sielken RL
    J Environ Pathol Toxicol; 1977; 1(2):241-78. PubMed ID: 553133
    [No Abstract]   [Full Text] [Related]  

  • 32. The scientific aspects of carcinogens at work as seen by the Institute of Occupational Health in Oslo.
    Norseth T
    Med Lav; 1986; 77(4):338-42. PubMed ID: 3784940
    [No Abstract]   [Full Text] [Related]  

  • 33. Foreword: Biomonitoring Equivalents special issue.
    Meek ME; Sonawane B; Becker RA
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S3. PubMed ID: 18395953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of some aspects of quantitative risk assessment.
    Fishbein L
    J Toxicol Environ Health; 1980; 6(5-6):1275-96. PubMed ID: 7007657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biologically effective dose biomarkers].
    Miraglia N; Assennato G; Clonfero E; Fustinoni S; Sannolo N
    G Ital Med Lav Ergon; 2004; 26(4):298-301. PubMed ID: 15584436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomonitoring Equivalents (BE) dossier for trihalomethanes.
    Aylward LL; LaKind JS; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S68-77. PubMed ID: 18579267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex mixtures and cancer risk.
    IARC Sci Publ; 1990; (104):1-8. PubMed ID: 2228105
    [No Abstract]   [Full Text] [Related]  

  • 38. ATSDR evaluation of health effects of benzene and relevance to public health.
    Wilbur S; Wohlers D; Paikoff S; Keith LS; Faroon O
    Toxicol Ind Health; 2008; 24(5-6):263-398. PubMed ID: 19022880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of pharmacogenetics on toxicological studies. Statistical implications.
    Lovell DP
    J Exp Anim Sci; 1993 Sep; 35(5-6):259-81. PubMed ID: 8218441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.